McNabb-Baltar_2020_Am.J.Gastroenterol__

Reference

Title : Lipase Elevation in Patients With COVID-19 - McNabb-Baltar_2020_Am.J.Gastroenterol__
Author(s) : McNabb-Baltar J , Jin DX , Grover AS , Redd WD , Zhou JC , Hathorn KE , McCarty TR , Bazarbashi AN , Shen L , Chan WW
Ref : Am J Gastroenterol , : , 2020
Abstract :

INTRODUCTION: Although coronavirus disease (COVID-19) has been associated with gastrointestinal manifestations, its effect on the pancreas remains unclear. We aimed to assess the frequency and characteristics of hyperlipasemia in patients with COVID-19. METHODS: A retrospective cohort study of hospitalized patients across 6 US centers with COVID-19. RESULTS: Of 71 patients, 9 (12.1%) developed hyperlipasemia, with 2 (2.8%) greater than 3 times upper limit of normal. No patient developed acute pancreatitis. Hyperlipasemia was not associated with poor outcomes or symptoms. DISCUSSION: Although a mild elevation in serum lipase was observed in some patients with COVID-19, clinical acute pancreatitis was not seen.

PubMedSearch : McNabb-Baltar_2020_Am.J.Gastroenterol__
PubMedID: 32496339

Related information

Citations formats

McNabb-Baltar J, Jin DX, Grover AS, Redd WD, Zhou JC, Hathorn KE, McCarty TR, Bazarbashi AN, Shen L, Chan WW (2020)
Lipase Elevation in Patients With COVID-19
Am J Gastroenterol :

McNabb-Baltar J, Jin DX, Grover AS, Redd WD, Zhou JC, Hathorn KE, McCarty TR, Bazarbashi AN, Shen L, Chan WW (2020)
Am J Gastroenterol :